Physician profile
Jorge Gardyn
NPI 1629060983
$3,620.35
in general payments reported to CMS, 2019-2025
28 companies · $852 in 2025
The $852 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $74.88 · 2021: $485 · 2022: $355 · 2023: $509 · 2024: $632 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,993.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $872.48 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $842.05 | 2019-2025 | Otezla, Repatha, Repatha |
| Genentech USA, INC. | $201.71 | 2019-2022 | |
| Pfizer INC. | $198.53 | 2025 | |
| Novo Nordisk INC | $186.86 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $165.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $134.77 | 2021-2022 | |
| Lilly USA, LLC | $129.35 | 2020-2025 | Mounjaro, Zepbound |
| Regeneron Healthcare Solutions, INC. | $124.00 | 2025 | Dupixent |
| Intuitive Surgical, INC. | $120.00 | 2025 | |
| Medtronic USA, INC. | $117.22 | 2019 | |
| Corcept Therapeutics | $67.72 | 2024 | Korlym |
| Intra-Sana Laboratories | $50.00 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Merck Sharp & Dohme LLC | $43.32 | 2024-2025 | Lagevrio |
| Dexcom, INC. | $42.51 | 2023-2024 | Dexcom G6 Transmitter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $40.82 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Novartis Pharmaceuticals Corporation | $37.46 | 2019-2022 | |
| Shield Therapeutics INC | $32.36 | 2023 | Accrufer |
| Medicomp INC | $32.14 | 2025 | Telepatch Cardiac Monitor |
| Philips North America LLC | $27.50 | 2025 | Mcot |
| Linus Health, INC. | $26.15 | 2023 | |
| Sanofi-Aventis U.S. LLC | $24.05 | 2024 | |
| Exact Sciences Corporation | $19.50 | 2024 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $19.42 | 2022 | |
| Glaxosmithkline, LLC. | $18.42 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.94 | 2019 | |
| Vistapharm, INC. | $14.61 | 2021 | |
| Sanofi Pasteur INC. | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Gardyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.